EvodiaBio has secured EUR 6 million in funding led by RA Capital to accelerate its growth and expand into Asian markets, leveraging its innovative sustainable aroma production technology.
Information on the Target
EvodiaBio is an innovative Danish industrial biotech firm specializing in sustainable aroma production through fermentation processes. Having transitioned from a research initiative to a profitable industrial operation, the company has garnered strong commercial traction, evidenced by more than 70 brews and various projects with top global breweries. With a focus on developing efficient and environmentally sustainable methods for producing volatile aroma molecules, EvodiaBio aims to replace traditional resources like hops—currently threatened by climate change—thereby reshaping the beer and broader beverage industry.
The company has raised EUR 6 million in its latest funding round, which will facilitate growth in existing markets across Europe, the USA, and Canada, while also paving the way for entry into the Asian market. This funding reflects EvodiaBio's commitment to scaling its operations and further developing its technology to meet rising global demand.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Denmark
The beverage industry in Denmark is rapidly evolving, characterized by an increasing focus on sustainability and innovation. Consumer preferences are shifting towards natural and eco-friendly products, creating an opportunity for co
Similar Deals
Syndicate of five investors from Keystones and DanBAN → OfficeFit
2025
Lundbeck Foundation BioCapital, EIR Ventures, EIFO, UCPH Ventures → Dania Therapeutics
RA Capital
invested in
EvodiaBio
in 2025
in a Other VC deal
Disclosed details
Transaction Size: $7M